1394034-59-3

Basic information

• Product Name: 2-bromo-1-(5-bromo-1-methyl-1H-pyrazol-4-yl)ethanone
• CAS NO: 1394034-59-3
• Molecular Weight: 281.934
• Mol File: 1394034-59-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-bromo-1-(5-bromo-1-methyl-1H-pyrazol-4-yl)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-1-(5-bromo-1-methyl-1H-pyrazol-4-yl)ethanone(1394034-59-3)
• EPA Substance Registry System: 2-bromo-1-(5-bromo-1-methyl-1H-pyrazol-4-yl)ethanone(1394034-59-3)

Safety Data

• Hazardous Substances Data: 1394034-59-3(Hazardous Substances Data)

Upstream product

• 54367-67-8 5-bromo-1-methyl-1H-pyrazole-4-carboxylic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 31037-02-2 ethyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate 
• 105486-72-4 5-bromo-1-methyl-1H-pyrazole-4-carboxylic acid ethyl ester 

Downstream Products

• 1394034-69-5 N-(4-methoxybenzyl)-N,7-dimethyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f ][1,2,4]triazin-4-amine 
• 1394034-71-9 5-(5-bromo-1-methyl-1H-pyrazol-4-yl)-N-(4-methoxybenzyl)-N,7-dimethylimidazo[5,1-f][1,2,4]triazin-4-amine 
• 1394033-60-3 4-(azetidin-1-yl)-5-[5-(4-methoxy-2-methylphenyl)-1-methyl-1H-pyrazol-4-yl]-7-methylimidazo[5,1-f][1,2,4]triazine 
• 1394034-73-1 7-methyl-5-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)imidazo[5,1-f ][1,2,4]triazin-4(3H)-one 
• 1394033-58-9 5-{5-[4-(difluoromethyl)phenyl]-1-methyl-1H-pyrazol-4-yl}-N,7-dimethylimidazo[5,1-f][1,2,4]triazin-4-amine 
• 1394033-61-4 [4-(methylamino)-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazin-7-yl]methanol 
• 1394033-66-9 4-(azetidin-1-yl)-7-methyl-5-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)imidazo[5,1-f ][1,2,4]-triazine 

Relevant articles and documents

Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate

Computational modeling was used to direct the synthesis of analogs of previously reported phosphodiesterase 2A (PDE2A) inhibitor 1 with an imidazotriazine core to yield compounds of significantly enhanced potency. The analog PF-05180999 (30) was subsequen